Group One Trading
RNAM

Group One Trading’s Avidity Biosciences RNAM Stock Holding History

Group One Trading’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-18,571
Closed -$1.34M – 8569
2025
Q4 		$1.34M Sell
18,571
-20,625
-53% -$1.33M ﹤0.01% 2630
2025
Q3 		$1.71M Buy
39,196
+15,902
+68% +$643K ﹤0.01% 2469
2025
Q2 		$662K Sell
23,294
-10,483
-31% -$312K ﹤0.01% 3147
2025
Q1 		$997K Buy
+33,777
New +$1.05M ﹤0.01% 2467
2024
Q4 		– Sell
-3,091
Closed -$129K – 7862
2024
Q3 		$142K Buy
3,091
+1,244
+67% +$54K ﹤0.01% 3903
2024
Q2 		$75.5K Buy
1,847
+938
+103% +$26.9K ﹤0.01% 4187
2024
Q1 		$23.2K Buy
+909
New +$14.2K ﹤0.01% 5312
2023
Q3 		– Sell
-5,413
Closed -$46.6K – 8194
2023
Q2 		$60K Buy
5,413
+5,112
+1,698% +$64.1K ﹤0.01% 5112
2023
Q1 		$4.62K Buy
+301
New +$6.62K ﹤0.01% 6315

Other funds holding RNAM

CC
Corsicana & Co Corsicana, Texas $158M AUM

Group One Trading's RNAM Position: Q1 2026 in Review

Group One Trading sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 18,571 shares — an estimated $1.34M sold.

Group One Trading first reported a position in RNAM in Q1 2023 and held it in 9 quarters. The position peaked at $1.71M in Q3 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • Group One Trading reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • Group One Trading sold 18,571 Avidity Biosciences shares in Q1 2026, an estimated $1.34M.
  • Group One Trading first reported a position in Avidity Biosciences in Q1 2023 and held it in 9 quarters.
  • Group One Trading's Avidity Biosciences position peaked at $1.71M in Q3 2025.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.